540 related articles for article (PubMed ID: 20664470)
1. The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems.
Klimstra DS; Modlin IR; Coppola D; Lloyd RV; Suster S
Pancreas; 2010 Aug; 39(6):707-12. PubMed ID: 20664470
[TBL] [Abstract][Full Text] [Related]
2. Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set.
Klimstra DS; Modlin IR; Adsay NV; Chetty R; Deshpande V; Gönen M; Jensen RT; Kidd M; Kulke MH; Lloyd RV; Moran C; Moss SF; Oberg K; O'Toole D; Rindi G; Robert ME; Suster S; Tang LH; Tzen CY; Washington MK; Wiedenmann B; Yao J
Am J Surg Pathol; 2010 Mar; 34(3):300-13. PubMed ID: 20118772
[TBL] [Abstract][Full Text] [Related]
3. Pathology reporting of neuroendocrine tumors: essential elements for accurate diagnosis, classification, and staging.
Klimstra DS
Semin Oncol; 2013 Feb; 40(1):23-36. PubMed ID: 23391110
[TBL] [Abstract][Full Text] [Related]
4. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
[TBL] [Abstract][Full Text] [Related]
5. Current knowledge on diagnosis and staging of neuroendocrine tumors.
Oberg K; Castellano D
Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():3-7. PubMed ID: 21311954
[TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification.
Anlauf M
Horm Metab Res; 2011 Nov; 43(12):825-31. PubMed ID: 22105474
[TBL] [Abstract][Full Text] [Related]
7. Ki-67 is a powerful tool for grading neuroendocrine tumors among Egyptian patients: a 10-year experience.
Salama A; Badawy O; Mokhtar N
J Cancer Res Clin Oncol; 2014 Apr; 140(4):653-61. PubMed ID: 24515911
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine tumors of midgut and hindgut origin: tumor-node-metastasis classification determines clinical outcome.
Jann H; Roll S; Couvelard A; Hentic O; Pavel M; Müller-Nordhorn J; Koch M; Röcken C; Rindi G; Ruszniewski P; Wiedenmann B; Pape UF
Cancer; 2011 Aug; 117(15):3332-41. PubMed ID: 21246527
[TBL] [Abstract][Full Text] [Related]
9. Grading of neuroendocrine tumors with Ki-67 requires high-quality assessment practices.
Remes SM; Tuominen VJ; Helin H; Isola J; Arola J
Am J Surg Pathol; 2012 Sep; 36(9):1359-63. PubMed ID: 22895268
[TBL] [Abstract][Full Text] [Related]
10. Histologic grade is correlated with outcome after resection of hepatic neuroendocrine neoplasms.
Cho CS; Labow DM; Tang L; Klimstra DS; Loeffler AG; Leverson GE; Fong Y; Jarnagin WR; D'Angelica MI; Weber SM; Blumgart LH; Dematteo RP
Cancer; 2008 Jul; 113(1):126-34. PubMed ID: 18457323
[TBL] [Abstract][Full Text] [Related]
11. Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a practical diagnostic approach to high-grade (G3) cases.
Singhi AD; Klimstra DS
Histopathology; 2018 Jan; 72(1):168-177. PubMed ID: 29239037
[TBL] [Abstract][Full Text] [Related]
12. Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum.
Seidman JD; Horkayne-Szakaly I; Cosin JA; Ryu HS; Haiba M; Boice CR; Yemelyanova AV
Gynecol Oncol; 2006 Nov; 103(2):703-8. PubMed ID: 16828848
[TBL] [Abstract][Full Text] [Related]
13. Future perspectives on neuroendocrine tumors.
Castellano D; Salazar R; Raymond E
Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():35-40. PubMed ID: 21327890
[TBL] [Abstract][Full Text] [Related]
14. [Definition and histologic characterization of neuroendocrine tumors].
Saint-André JP; Valo I; Guyétant S
Rev Prat; 2002 Feb; 52(3):250-5. PubMed ID: 11925713
[TBL] [Abstract][Full Text] [Related]
15. Aspects regarding nomenclature, classification and pathology of neuroendocrine neoplasms of the digestive system - a review.
Păun I; Becheanu G; Costin AI; Constantin VD; Mihai GM; Radu L; Iovan L; Vârcuş F
Rom J Morphol Embryol; 2018; 59(3):673-678. PubMed ID: 30534804
[TBL] [Abstract][Full Text] [Related]
16. Classification of low-grade neuroendocrine tumors of midgut and unknown origin.
Van Eeden S; Quaedvlieg PF; Taal BG; Offerhaus GJ; Lamers CB; Van Velthuysen ML
Hum Pathol; 2002 Nov; 33(11):1126-32. PubMed ID: 12454818
[TBL] [Abstract][Full Text] [Related]
17. Gastroenteropancreatic neuroendocrine neoplasms: historical context and current issues.
Yang Z; Tang LH; Klimstra DS
Semin Diagn Pathol; 2013 Aug; 30(3):186-96. PubMed ID: 24144288
[TBL] [Abstract][Full Text] [Related]
18. Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors.
Klöppel G; Rindi G; Anlauf M; Perren A; Komminoth P
Virchows Arch; 2007 Aug; 451 Suppl 1():S9-27. PubMed ID: 17684761
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?
Scherübl H; Cadiot G; Jensen RT; Rösch T; Stölzel U; Klöppel G
Endoscopy; 2010 Aug; 42(8):664-71. PubMed ID: 20669078
[TBL] [Abstract][Full Text] [Related]
20. Sporadically occurring functional pancreatic endocrine tumors: review of recent literature.
Goldin SB; Aston J; Wahi MM
Curr Opin Oncol; 2008 Jan; 20(1):25-33. PubMed ID: 18043253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
